---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-072953"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:35:03.874986+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Journey Medical shareholders approve 3M-share increase to equity plan, re-elect directors

## Summary
- Shareholders approved amendment to 2015 Stock Plan increasing shares from 4,642,857 to 7,642,857 (a 64.6% increase).
- All six director nominees elected: Rosenwald, Maraoui, Herskowitz, Paley, Smith, Toledano.
- Ratification of KPMG as independent auditor for fiscal 2022 approved with 19,887,190 votes for.
- Plan amendment became effective upon stockholder approval on June 21, 2022.

## SEC filing metadata
- accession: 0001104659-22-072953
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465922072953/0001104659-22-072953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465922072953/tm2219018d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-072953
- JSON: https://secwatch.observer/filing/0001104659-22-072953.json
- Plain text: https://secwatch.observer/filing/0001104659-22-072953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.